Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT00363025 Org: User:
Start: 11/30/99 End: 04/30/06 Due: 04/30/07

Multicenter Retrospective Observatory of Patients With Acute Myeloid Leukemia to Core Binding Factor

Phase: N/A Priority: Normal
NCT ID: NCT05070208 Org: User:
Start: 09/22/21 End: 01/25/24 Due: 01/25/25

A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT00927498 Org: User:
Start: 12/31/07 End: 07/31/13 Due: 07/31/14

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Phase: N/A Priority: Normal
NCT ID: NCT00931138 Org: User:
Start: 12/31/99 End: 12/31/06 Due: 12/31/07

Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00880243 Org: User:
Start: 03/31/99 End: 09/30/06 Due: 09/30/07

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT04777916 Org: User:
Start: 04/14/22 End: 04/01/46 Due: 04/01/47

DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML

Phase: N/A Priority: Normal
NCT ID: NCT02182596 Org: User:
Start: 06/30/06 End: 01/31/11 Due: 01/31/12

ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01067274 Org: User:
Start: 04/30/10 End: - Due: -